Stay updated on KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Sign up to get notified when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.

Latest updates to the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page
- Check3 days agoChange DetectedAdded a government funding lapse notice on the page informing users that information may not be up to date and actions may be delayed. Updated the system revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check10 days agoChange DetectedUI and metadata updates were made: a glossary toggle was added, QC-related date label capitalization was updated, No FEAR Act data capitalization was normalized, and the site revision updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays revision v3.3.4, replacing the previous v3.3.3.SummaryDifference0.1%

- Check45 days agoChange DetectedA new Locations section is added listing study sites in New York, Ohio, and Texas, consolidating location information that was previously shown as separate location entries.SummaryDifference0.5%

- Check74 days agoChange DetectedRevision: v3.3.2 added; Revision: v3.2.0 removed. These are minor site version updates and do not affect the study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe government funding lapse notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.